Proteros

About:

Proteros is a biotech company focused on enabling lead discovery for challenging targets.

Website: https://www.proteros.com/

Twitter/X: proteros_munich

Top Investors: Inflexion, BayBG Venture Capital

Description:

Proteros is a biotech company focused on enabling lead discovery for challenging targets. Proteros has established a profitable discovery service business with a best-in-class enabling technology platform for structure accelerated lead discovery. Their track record is proven by an outstanding project success rate. Proteros’ proprietary pipeline includes highly disease relevant target classes such as kinases, epigenetic targets and GPCRs. Their success is built on unique know how and expertise in understanding the role of protein structures involved in protein and small molecule interactions that are responsible for the pathogenesis of many diseases.

Total Funding Amount:

5.2M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Martinsried, Bayern, Germany

Founded Date:

1998-01-01

Contact Email:

business(AT)proteros.de

Founders:

Torsten Neuefeind

Number of Employees:

51-100

Last Funding Date:

2023-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai